Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua L Andersen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Structure (London, England : 1993)|September 30, 2023
Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domainSupeshala Nawarathnage, Yi Jie Tseng, Sara Soleimani, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domainSupeshala Nawarathnage, Yi Jie Tseng, Sara Soleimani, et al.
Oncotarget|February 8, 2019
Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic driftMonique M P Speirs, Adam C Swensen, Tsz Y Chan, et al.
Molecular and Cellular Biology|July 26, 2017
Acylation of Superoxide Dismutase 1 (SOD1) at K122 Governs SOD1-Mediated Inhibition of Mitochondrial RespirationCourtney J Banks, Nathan W Rodriguez, Kyle R Gashler, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Nature Communications|September 10, 2021
TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growthTsz-Yin Chan, Christina M Egbert, Julia E Maxson, et al.
Blood Cancer Discovery|May 24, 2021
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIADongqing Yan, Anca Franzini, Anthony D Pomicter, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Structure (London, England : 1993)|September 30, 2023
Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domainSupeshala Nawarathnage, Yi Jie Tseng, Sara Soleimani, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Fusion crystallization reveals the behavior of both the 1TEL crystallization chaperone and the TNK1 UBA domainSupeshala Nawarathnage, Yi Jie Tseng, Sara Soleimani, et al.
Oncotarget|February 8, 2019
Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic driftMonique M P Speirs, Adam C Swensen, Tsz Y Chan, et al.
Molecular and Cellular Biology|July 26, 2017
Acylation of Superoxide Dismutase 1 (SOD1) at K122 Governs SOD1-Mediated Inhibition of Mitochondrial RespirationCourtney J Banks, Nathan W Rodriguez, Kyle R Gashler, et al.
Cell Reports|March 21, 2026
Identification and characterization of BRAF⇔TP53 interactions in melanomaKayla T O'Toole, Adamaris Martinez, Brandon Murphy, et al.
Nature Communications|September 10, 2021
TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growthTsz-Yin Chan, Christina M Egbert, Julia E Maxson, et al.
Blood Cancer Discovery|May 24, 2021
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIADongqing Yan, Anca Franzini, Anthony D Pomicter, et al.
Pageof 4